AUTHORS

Real Money authors - Bruce Kamich

Bruce Kamich

Bruce Kamich is TheStreet's in-house technical analyst with a 43 year career with a number of bulge bracket firms like Morgan Stanley, Smith Barney Harris Upham, and Merrill Lynch. Along the way he accumulated knowledge about the fundamentals of the commodity markets, interest rates, equities and ETFs. 

In addition to writing for theStreet.com Kamich has been teaching technical analysis at Baruch College for the past twenty years.

Kamich was one of the earliest Chartered Market Technicians  or CMTs, a professional designation similar to the CFA title. He has authored two books on charting and technical analysis - "How Technical Analysis Works"  and "Chart Patterns." He is a two-time past president of the Market Technicians Association (now called the CMTA), the professional organization for chartists worldwide. He was also the president of the Market Technicians Association Educational Foundation (MTAEF.org).
Email Bruce Kamich

Recent Articles By The Author

When Duty Calls: How to Play Recent IPO PagerDuty

PD could rally further after a retest of the November low.

Semiconductor Stock Inphi Is Poised for Further Gains

Prices have been in an uptrend the past 12 months for the California-based chip name.

After Upgrade, Nuance Set for Gains

NUAN was upgraded to a Buy by TheStreet's quantitative service.

Avoid the Long Side of Urban Outfitters Shares as They Could Sink Further

Let's check out the charts of this retailer.

Intuit Is Set to Climb Higher: Here's When We Would Buy

Our latest technical analysis and trading strategy for the maker of TurboTax.

Macy's Stock Performance Is Likely to Remain a Turkey

The bears already were in control of the iconic retailer's shares even before it posted a third-quarter revenue miss.

Okta Looks OK to Add to Its Impressive Gains

The tech company's shares already have doubled in value in 2019 and its charts indicate the rise likely isn't over.

Kohl's Charts Look Vulnerable to Further Steep Losses

Let's check the charts of this retailer.

Novartis Is Moving Higher on the Charts, Go Long or Add to Longs

Let's check in on this Swiss-based pharmaceutical giant.

How to Play Salesforce as New Highs Loom Ahead

Keep an eye on trading volume.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight